Star Combo (Australia) Performance
| S66 Stock | 0.15 0.01 7.14% |
On a scale of 0 to 100, Star Combo holds a performance score of 3. The entity has a beta of -0.36, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Star Combo are expected to decrease at a much lower rate. During the bear market, Star Combo is likely to outperform the market. Please check Star Combo's coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to make a quick decision on whether Star Combo's existing price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Star Combo Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Star Combo unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0247 | Ex Dividend Date 2024-10-14 |
1 | Should You Be Worried About Strides Pharma Science Limiteds 7.8 percent Return On Equity - Simply Wall St | 11/18/2024 |
2 | Eli Lilly and Company Quote - Press Release - The Globe and Mail | 11/27/2024 |
3 | Payoneer Emerging Star Currently Drowning In Cash - Seeking Alpha | 12/10/2024 |
| Begin Period Cash Flow | 3 M |
Star |
Star Combo Relative Risk vs. Return Landscape
If you would invest 14.00 in Star Combo Pharma on October 6, 2024 and sell it today you would earn a total of 1.00 from holding Star Combo Pharma or generate 7.14% return on investment over 90 days. Star Combo Pharma is generating 0.2343% of daily returns assuming 4.9636% volatility of returns over the 90 days investment horizon. Simply put, 44% of all stocks have less volatile historical return distribution than Star Combo, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Star Combo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Star Combo's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Star Combo Pharma, and traders can use it to determine the average amount a Star Combo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0472
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | S66 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.96 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Star Combo is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Star Combo by adding it to a well-diversified portfolio.
Star Combo Fundamentals Growth
Star Stock prices reflect investors' perceptions of the future prospects and financial health of Star Combo, and Star Combo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Star Stock performance.
| Return On Equity | 0.0224 | ||||
| Return On Asset | 0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 16.93 M | ||||
| Shares Outstanding | 135.08 M | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 0.78 X | ||||
| Revenue | 26.02 M | ||||
| Gross Profit | 4.82 M | ||||
| EBITDA | 2.79 M | ||||
| Net Income | 747.33 K | ||||
| Cash And Equivalents | 6.5 M | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | (316.45 K) | ||||
| Earnings Per Share | 0.01 X | ||||
| Total Asset | 42.82 M | ||||
| Retained Earnings | (10.08 M) | ||||
About Star Combo Performance
Assessing Star Combo's fundamental ratios provides investors with valuable insights into Star Combo's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Star Combo is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Star Combo is entity of Australia. It is traded as Stock on AU exchange.Things to note about Star Combo Pharma performance evaluation
Checking the ongoing alerts about Star Combo for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Star Combo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Star Combo Pharma has some characteristics of a very speculative penny stock | |
| Star Combo Pharma had very high historical volatility over the last 90 days | |
| Star Combo Pharma is unlikely to experience financial distress in the next 2 years | |
| Star Combo Pharma has accumulated about 6.5 M in cash with (316.45 K) of positive cash flow from operations. | |
| Roughly 94.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Payoneer Emerging Star Currently Drowning In Cash - Seeking Alpha |
- Analyzing Star Combo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Star Combo's stock is overvalued or undervalued compared to its peers.
- Examining Star Combo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Star Combo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Star Combo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Star Combo's stock. These opinions can provide insight into Star Combo's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Star Stock Analysis
When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.